328 related articles for article (PubMed ID: 35429848)
1. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
[TBL] [Abstract][Full Text] [Related]
2. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
3. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
4. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
5. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
6. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
[TBL] [Abstract][Full Text] [Related]
7. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
8. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
10. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
Murthy R; Bagchi A; Gote Y; Desai S
Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
13. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
[TBL] [Abstract][Full Text] [Related]
15. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
[TBL] [Abstract][Full Text] [Related]
16. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
20. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
